济南性生活中时间短怎么办(济南有几家专业男科医院) (今日更新中)

More than two years ago, students at Marjory Stoneman Douglas High School turned their grief and anguish into activism after their school tragedy.Many of those students who were part of that movement are voting in their first presidential election."I was very proud to vote," said Buchwald.Buchwald and Hibshman are now Marjory Stoneman Douglas High School alumni. They were juniors in 2018 when a gunman opened fire in Building 12 at the school, killing 17 people."[The shooting] still brings moments of fear and sadness back," said Hibshman. After the Parkland school shooting in 2018, Zach Hibshman and Adam Buchwald started the group "Parents Promise to Kids" to push for stricter gun laws. "Before the shooting, this wouldn't be part of my everyday life. I wouldn’t be an activist. I'd be a normal kid doing my homework and studying for the ACT," Zach said more than two years ago.They pushed to bring about change in the wake of tragedy, starting the group "Parents Promise to Kids."The movement called on people to sign a contract pledging to vote for politicians who support stricter gun laws."[The group] exploded across the country, and we got so many signatures," said Buchwald.But something was missing at the time leading up to the midterm-elections nearly two years ago. They were too young to vote."That was one of the things Adam and I so desperately wanted to do," said Hibshman. "The fact that we couldn't share our thoughts through the form of a ballot, after we went through all that, was pretty frustrating."Hibshman and Buchwald are now sophomores at the University of Florida and eligible to vote.The memory of the 17 people killed at their former school is on their minds as they cast their ballots."Definitely going to think about gun control," said Hibshman."The topic of gun control is extremely important, but so is COVID," said Buchwald.Finally, they can make their voices heard on a ballot.Buchwald has now started a new movement with his brother, Josh, called "Promise to Humanity." They ask people to sign a contract, pledging to wear a mask, and practice social distancing during the pandemic. This article was written by Alex Hagan for WPTV. 2228

The Toronto Raptors will be starting the 2020-21 NBA season in Tampa, the team said in a statement Friday.Raptors owner Masai Ujiri released the following statement:“The Raptors worked diligently with public health officials at the local, provincial and federal level to secure a plan that would permit us to play our 2020-21 season on home soil and on our home court at Scotiabank Arena. These conversations were productive, and we found strong support for the protocols we put forward. Ultimately, the current public health situation facing Canadians, combined with the urgent need to determine where we will play means that we will begin our 2020-21 season in Tampa, Florida.We want to thank all levels of government and their public health officials for their dedication to this process, and for looking after the health of Canadians. We commit to continuing our work together, planning for a safe return to play in Toronto. And as an organization, we remain committed to doing all we can to promote and demonstrate public health measures to help combat the spread of COVID-19 in Canada.So we’ll be away from our home and our fans for now. They say absence makes the heart grow fonder. I’m not sure that’s possible for us – we love Toronto and Canada, and we know we have the best fans in the NBA. For now, I’ll ask you to cheer for us from afar, and we’ll look forward to the day we are all together again.”Games will be played at AMALIE Arena, home of the Tampa Bay Lightning.Even Lightning Captain Steven Stamkos was excited about the news:“ WE THE SOUTH” ?? https://t.co/hVHlJKItrh— Steven Stamkos (@RealStamkos91) November 20, 2020 This past MLB season, the Toronto Blue Jays had to make their home in Buffalo due to Canada's COVID-19 restrictions.The NBA season tips off on Dec. 22. This story originally reported by Dan Trujillo on ABCActionNews.com 1883

DENVER, Colo. – At Stoney’s Bar and Grill in Denver, the entire front of the house is trying something new for the new year: giving up alcohol. Well, at least for the first 31 days of 2020. “I probably spent a thousand bucks every two weeks on booze,” said bartender Adam Farrenkopf. In attempt to save his money and his health, Farrenkopf is participating in what’s called “Dry January” – an international health movement urging people to abstain from alcohol for the first month of the year. “Being a bartender, it’s hard to not drink,” Farrenkopf said. “It’s a testament to myself and we’ll see what happens.” Dry January started a few years ago in the U.K. and quickly spread to the U.S. And it’s catching on fast. A recent study by Nielsen found just over one-fifth of Americans took part in Dry January last year and 83% of those people said they planned on doing it again this year. But is doing this DIY detox right for you?“I think America has a love-hate relationship with alcohol,” said professor Tricia Hudson-Matthew, an addiction specialist with MSU Denver. She says giving up drinking has multiple benefits. “I would say financial, we spend a lot of money on it,” Hudson-Matthew said. “When we’re talking about health wise, we’re talking about better sleeping, better eating, better skin care.” To stay committed while going cold turkey, Hudson-Matthew says to have a plan in place like recruiting friends – or at least let them know what you’re doing. “When you take something away from an individual, you also have to replace it with something,” she said. “If there isn’t something that’s replacing it, then chances are, they are going to relapse and go right back to it.” Back at the bar, not everyone feels they need to give up drinking. “Nope. No Dry January for me,” said patron Jacque Lynn. “I’m pretty confident in my drinking abilities and not to drink when I need to not drink.”For people like Farrenkopf, however, they plan on taking this break from booze past the end of the month, and hangout without the hangover. 2060

HONG KONG – Hong Kong authorities on Wednesday withdrew an unpopular extradition bill that sparked months of chaotic protests that have since morphed into a campaign for greater democratic change. "As a result of the divided views of the public regarding the (extradition) bill, there have been conflicts in the society," Secretary for Security John Lee told the city's legislature. Lee said the administration decided to suspend the amendment exercise after studying the matter. “For this purpose I wrote to the president of Legco (Legislative Council) to withdraw the notice to resume the second reading of the bill,” Lee said. “And as a result, the Legislative Council meeting stopped handling the bill. Thereafter, the administration stated many times that the revision has come to a halt. For the purpose of spelling out clearly the position of the special administrative region government, in the accordance of Rule 64(2), I formally announce the withdrawal of the bill.” Pro-democracy lawmakers immediately tried to question him but he refused to respond and the assembly's president said the rules did not allow for debate.The long-expected scrapping of the bill was overshadowed by the drama surrounding the release from a Hong Kong prison of the murder suspect at the heart of the extradition case controversy.Chan Tong-kai told reporters after leaving prison that he was willing to turn himself into authorities in Taiwan, where he is wanted for the killing of his girlfriend. He was released after serving a separate sentence for money laundering offenses.Chan could not be sent to Taiwan because there's no extradition agreement in place.Hong Kong's leader had amendments in a bid to eliminate the loophole, but it sparked widespread protests over concerns it put residents at risk of being sent into mainland China's murky judicial system. 1868

CHICAGO, Ill. – Scientists have identified nearly 70 drugs that could be effective in treating the coronavirus. But already, some drugs are being improperly prescribed or hoarded even before they can be adequately investigated and tested. For some who rely on the life-saving drugs for other ailments, shortages are already being felt. Across the country, some people with chronic illnesses are finding their much-needed medications are on backorder. One drug in short supply is Plaquenil, generically known as hydroxychloroquine sulfate. It’s used to treat malaria and chronic rheumatic diseases. “It prevents them from having severe pain, from their symptoms getting worse, from forming modules. This is a daily medication that these people absolutely need,” said Erin Fox, who’s with the American Society of Health-System Pharmacists. Fox, who maintains a list of nationwide drug shortages, says four of the eight producers of hydroxychloroquine are running out. “We’ve definitely seen a rapid increase in demand for this product,” she said. “I think it’s a frustrating problem and I think it’s really scary for those patients that rely on this medication day in and day out.” While hydroxychloroquine is not FDA-approved as an off-label treatment option for novel coronavirus, it has already been touted by the president as a potential game-changer. “Millions of units are ordered, and we’re going to see what happens,” said President Donald Trump. “We’re going to be talking to the governors about it, and the FDA is working on it right now.” Last week, a French study of just 20 people reported 70% of coronavirus patients treated with Plaquenil after six days tested negative for the virus, compared to 12.5% of the control group. Hospitals across the country are stockpiling it as a precaution. The state of New York has already acquired 70,000 doses as part of its own drug trials this week. But with no large-scale clinical data available, public health officials warn it’s too early to know whether the drug is effective against coronavirus. When asked about hydroxychloroquine’s efficacy at a White House coronavirus task force brief late last week, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, said more studies are needed. “The information that you’re referring to specifically is anecdotal; it was not done in a controlled clinical trial,” said Fauci. “So, you really can’t make any definitive statement about it.” Dr. Jessica Nouhavandi, the lead pharmacist and CEO of L.A.-based online pharmacy 2574

来源：资阳报